These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 7407085
1. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. Janatova J, Lorenz PE, Schechter AN, Prahl JW, Tack BF. Biochemistry; 1980 Sep 16; 19(19):4471-8. PubMed ID: 7407085 [Abstract] [Full Text] [Related]
2. The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase. Kerr MA, Parkes C. Biochem J; 1984 Apr 15; 219(2):391-9. PubMed ID: 6611150 [Abstract] [Full Text] [Related]
3. Reduction of the beta-Cys-gamma-Glu thiol ester bond of human C3 with sodium borohydride. Thomas ML, Davidson FF, Tack BF. J Biol Chem; 1983 Nov 25; 258(22):13580-6. PubMed ID: 6139373 [Abstract] [Full Text] [Related]
4. Evidence for presence of an internal thiolester bond in third component of human complement. Tack BF, Harrison RA, Janatova J, Thomas ML, Prahl JW. Proc Natl Acad Sci U S A; 1980 Oct 25; 77(10):5764-8. PubMed ID: 6934510 [Abstract] [Full Text] [Related]
5. Sulfhydryl chemistry of Salmonella typhimurium phosphoribosylpyrophosphate synthetase: identification of two classes of cysteinyl residues. Harlow KW, Switzer RL. Arch Biochem Biophys; 1990 Feb 01; 276(2):466-72. PubMed ID: 2154950 [Abstract] [Full Text] [Related]
6. Third component of complement (C3): structural properties in relation to functions. Bokisch VA, Dierich MP, Mūller-Eberhard HJ. Proc Natl Acad Sci U S A; 1975 Jun 01; 72(6):1989-93. PubMed ID: 1056006 [Abstract] [Full Text] [Related]
7. Identification of the C3b receptor-binding domain in third component of complement. Becherer JD, Lambris JD. J Biol Chem; 1988 Oct 05; 263(28):14586-91. PubMed ID: 2971659 [Abstract] [Full Text] [Related]
8. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates. Antón LC, Ruiz S, Barrio E, Marqués G, Sánchez A, Vivanco F. Eur J Immunol; 1994 Mar 05; 24(3):599-604. PubMed ID: 8125130 [Abstract] [Full Text] [Related]
9. Inactivation of a cytosolic phospholipase A2 by thiol-modifying reagents: cysteine residues as potential targets of phospholipase A2. Li B, Copp L, Castelhano AL, Feng R, Stahl M, Yuan Z, Krantz A. Biochemistry; 1994 Jul 19; 33(28):8594-603. PubMed ID: 8031794 [Abstract] [Full Text] [Related]
10. Heat-induced thiol-disulfide interchange reaction on the third component of human complement, C3. Seya T, Nagasawa S. J Biochem; 1988 May 19; 103(5):792-6. PubMed ID: 3182749 [Abstract] [Full Text] [Related]
11. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. Pangburn MK, Müller-Eberhard HJ. J Exp Med; 1980 Oct 01; 152(4):1102-14. PubMed ID: 6903192 [Abstract] [Full Text] [Related]
12. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. Davis AE, Harrison RA, Lachmann PJ. J Immunol; 1984 Apr 01; 132(4):1960-6. PubMed ID: 6607952 [Abstract] [Full Text] [Related]
13. Location of the interchain disulfide bonds of the fourth component of human complement (C4): evidence based on the liberation of fragments secondary to thiol-disulfide interchange reactions. Seya T, Nagasawa S, Atkinson JP. J Immunol; 1986 Jun 01; 136(11):4152-6. PubMed ID: 3701066 [Abstract] [Full Text] [Related]
14. Covalent binding and hemolytic activity of complement proteins. Law SK, Lichtenberg NA, Levine RP. Proc Natl Acad Sci U S A; 1980 Dec 01; 77(12):7194-8. PubMed ID: 6938964 [Abstract] [Full Text] [Related]
15. Mapping of the properdin-binding site in the third component of complement. Lambris JD, Alsenz J, Schulz TF, Dierich MP. Biochem J; 1984 Jan 01; 217(1):323-6. PubMed ID: 6696726 [Abstract] [Full Text] [Related]
16. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. Pangburn MK, Schreiber RD, Müller-Eberhard HJ. J Exp Med; 1977 Jul 01; 146(1):257-70. PubMed ID: 301546 [Abstract] [Full Text] [Related]
17. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Isenman DE, Kells DI, Cooper NR, Müller-Eberhard HJ, Pangburn MK. Biochemistry; 1981 Jul 21; 20(15):4458-67. PubMed ID: 7284336 [Abstract] [Full Text] [Related]